Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank33
3Y CAGR-10.1%
5Y CAGR+0.2%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-10.1%/yr
Annual compound
5Y CAGR
+0.2%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.05 | -29.4% |
| 2024 | 0.07 | -3.4% |
| 2023 | 0.08 | +6.6% |
| 2022 | 0.07 | +286.7% |
| 2021 | 0.02 | -64.1% |
| 2020 | 0.05 | -67.1% |
| 2019 | 0.16 | - |